nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Erratum to: Inhibition of mTOR in carcinoid tumors
|
Grozinsky-Glasberg, Simona |
|
2012 |
7 |
3 |
p. 197 |
artikel |
2 |
Inhibition of mTOR in carcinoid tumors
|
Grozinsky-Glasberg, Simona |
|
2012 |
7 |
3 |
p. 189-195 |
artikel |
3 |
New treatment options with cytotoxic agents in neuroendocrine tumours
|
Hammel, Pascal |
|
2012 |
7 |
3 |
p. 169-172 |
artikel |
4 |
Place of surgical resection in the treatment strategy of gastrointestinal neuroendocrine tumors
|
Gaujoux, Sébastien |
|
2012 |
7 |
3 |
p. 153-159 |
artikel |
5 |
Profiling mTOR pathway in neuroendocrine tumors
|
Cingarlini, S. |
|
2012 |
7 |
3 |
p. 183-188 |
artikel |
6 |
Resistance to targeted therapies in pancreatic neuroendocrine tumors (PNETs): molecular basis, preclinical data, and counteracting strategies
|
Tijeras-Raballand, Annemilaï |
|
2012 |
7 |
3 |
p. 173-181 |
artikel |
7 |
Streptozocin-based chemotherapy is not history in neuroendocrine tumours
|
Weatherstone, Katie |
|
2012 |
7 |
3 |
p. 161-168 |
artikel |
8 |
Targeting ALK: a promising strategy for the treatment of non-small cell lung cancer, non-Hodgkin’s lymphoma, and neuroblastoma
|
Madrid, Andres Morales La |
|
2012 |
7 |
3 |
p. 199-210 |
artikel |
9 |
Targeting neuroendocrine tumor: mixing standard options with novel therapies
|
Raymond, Eric |
|
2012 |
7 |
3 |
p. 151-152 |
artikel |